Brazilian Dialysis Survey 2020

National data on chronic dialysis treatment are essential to support the development of health policies aimed at improving the treatment for thousands of people. To report epidemiological data from the 2020 Brazilian Dialysis Survey, sponsored by the Brazilian Society of Nephrology. A survey was car...

Full description

Saved in:
Bibliographic Details
Published inBrazilian Journal of Nephrology Vol. 44; no. 3; pp. 349 - 357
Main Authors Nerbass, Fabiana B, Lima, Helbert do Nascimento, Thomé, Fernando Saldanha, Vieira Neto, Osvaldo Merege, Lugon, Jocemir Ronaldo, Sesso, Ricardo
Format Journal Article
LanguageEnglish
Published Brazil Sociedade Brasileira de Nefrologia 01.09.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:National data on chronic dialysis treatment are essential to support the development of health policies aimed at improving the treatment for thousands of people. To report epidemiological data from the 2020 Brazilian Dialysis Survey, sponsored by the Brazilian Society of Nephrology. A survey was carried out in Brazilian chronic dialysis centers using an online questionnaire for the year, covering clinical and epidemiological aspects of patients in a chronic dialysis program, data on dialysis therapy, characteristics of dialysis units and the impact of the COVID-19 pandemic. 235 (28%) of the centers responded to the questionnaire. In July 2020, the estimated total number of patients on dialysis was 144,779. The estimated prevalence and incidence rates of patients per million population (pmp) were 684 and 209, respectively. Of the prevalent patients, 92.6% were on hemodialysis (HD) and 7.4% were on peritoneal dialysis (PD); 23% were on the transplant waiting list. A central venous catheter was used by a quarter of patients on HD. The incidence rate of confirmed COVID-19 between February and July 2020 was 684/10,000 dialysis patients, and the lethality rate was 25.7%. The estimated overall mortality and COVID-19 crude annual mortality rates were 24.5 and 4.2%, respectively. The absolute number of patients on chronic dialysis and prevalence rate continued to increase. The low use of PD as dialysis therapy was maintained and the use of long-term catheters for HD increased. The COVID-19 pandemic contributed to the increase in the overall mortality rate.
Bibliography:Authors’ Contribution
Authors declare no conflict of interest.
Conflict of Interest
All authors contributed substantially to the conception or design of the study; the collection, analysis or interpretation of data; writing the manuscript or its critical review; as well as the final approval of the version to be published.
ISSN:0101-2800
2175-8239
DOI:10.1590/2175-8239-JBN-2021-0198